A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN G3031 Compared to Placebo in Patients with Narcolepsy with and without Cataplexy

Updated on 27 January 2020
excessive daytime sleepiness


This is a study to evaluate how safe and effective an investigational medication (SUVN-G3031) is compared to placebo at reducing the excessive daytime sleepiness in patients with narcolepsy with or without cataplexy.


Condition Cataplexy, Cataplexy, Narcolepsy, Narcolepsy, Sleep Disorders
Clinical Study IdentifierTX235053
Last Modified on27 January 2020


Yes No Not Sure

Inclusion Criteria

People between 18 and 50 years of age diagnosed with narcolepsy with or without cataplexy
To be eligible patients must have no other conditions known to cause sleep disruption or excessive daytime sleepiness
No severe or uncontrolled heart, liver, kidney, gastrointestinal, neurological or psychiatric conditions
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note